Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report

10 January 2026 : Case report Taiwan

Unusual clinical course, Adverse events of drug therapy

Yu-Ming Chen

^{AEF 1}, Shangwen Chang

^{AF 1,2*}

DOI: 10.12659/AJCR.949867

Am J Case Rep 2026; 27:e949867

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Timeline of the case. PP1M – paliperidone palmitate once monthly; PP3M – paliperidone palmitate every 3 months.

Back to the Article